NEW YORK, Sept. 28, 2016 /PRNewswire/ -- Study coverage
Infection Prevention Products & Services analyzes the US market for infection prevention products and services. It offers historical data (2005, 2010 and 2015) plus forecasts (2020 and 2025) for demand by product and service, as well as by market. The study also considers market environment factors, details the industry structure, evaluates company market share and profiles 29 US competitors.
The US market for infection prevention products and services encompasses protective apparel and textiles, safety-enhanced medical devices, sterilization supplies, disinfectants, and waste disposal containers and accessories. Although declining, the overall rate of healthcare associated infections (HAIs) in hospitals is significantly above the target set by the Centers for Disease Control and Prevention. Increasing pressure on hospitals to improve results will boost revenues generated by infection prevention supplies, equipment and services. Additionally, the market will benefit from the upgrading of quality standards in life science research and pharmaceutical and medical device production facilities.
Protective apparel & textiles largest share of products
According to Infection Prevention Products & Services, a new report from The Freedonia Group, protective apparel and textiles will account for the largest share of infection prevention supplies as stepped-up efforts by hospitals to reduce the risk of HAIs in surgery and other invasive procedures broaden the use of premium, barrier-enhanced gloves, drapes, gowns, face masks, etc. Safety-enhanced medical devices will post the fastest growth in demand among infection prevention supplies as medical providers seek to improve the safety of blood collection, catheterization, drug delivery, and invasive surgical procedures. Safety-enhanced medical devices help reduce HAIs and prevent accidental needlesticks.
Extensive use of disinfectants continues
Efforts to reduce the incidence of HAIs, coupled with upward trends in the volume of patient procedures and life science activities, will boost the US market for disinfectants. These consumables, which are utilized widely in both healthcare and life science establishments, will benefit from the stricter enforcement of standards for staff and patient protection and facility and instrument cleaning. Trends promoting the use of premium formulations will underlie overall growth in disinfectant demand. The enforcement of infection prevention safeguards will also impact favorably on the market for infectious waste disposal supplies.
Waste disposal & sterilization services to drive revenue
Convenience, cost, and regulatory compliance advantages are predicted to expand infection prevention service revenues through 2020. Freedonia forecasts that infectious waste disposal services will dominate demand as government restrictions on onsite incineration remain and prompt health facilities to use outside firms for infectious waste collection and disposal. Contract sterilization services serve a more limited customer base and post a much lower revenue volume. Nonetheless, this segment is projected to grow measurably. To avoid the extensive capital investment required to set up and operate in-house sterilization systems, an increasing number of pharmaceutical and medical device producers will rely on outside contractors.
Read the full report: http://www.reportlinker.com/p0702281-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-infection-prevention-products--service-market-300336182.html